Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Gastroenterology. 2017 Mar 30;152(8):1845–1875. doi: 10.1053/j.gastro.2017.03.035

TABLE 1.

SP/KLF Family Members in the Digestive System

Adult GI system GI Disorder

Name Expression Function Expression Function

SP1 ESCC: Upregulated20 ESCC: Expression associated with LNM and TNM staging20

Stomach: Peptic cells of the stomach fundus36 Stomach: Promotes production of REG1 under stress-induced damage255; Stimulates the production of chromogranin A (CgA)38 Gastric cancer: Upregulated40, 41 Gastric cancer: Promotes cell invasion42

Pancreas: Acinar cells154, 162 Maintains acinar cell function by promoting expression of PTF1A154; Inhibits acinar cell proliferation by interacting with MIST1162 PDAC: Upregulated85 Regulates mucin production163-165; Regulates expression of KRT19 with KLF422

Pancreas: Beta cells155-157 Regulates expression of vesicular glucose transporter 2156 and pyruvate carboxylase157, and regulates expression of PDX1 with SP3155 Mild fasting hyperglycemia: mutation to the cis-regulatory region in Gck promoter156 Mutations cause loss of binding from SP1 to the cis-regulatory element156

Pancreas: Ductal epithelial cells153 Regulates expression of secretin receptor gene with SP3153

Liver192-194 Mediates response to oxidative stress192; Maintains expression of protein S193, 194 Cirrhotic Liver: Upregulated195 Increases fibrosis by increasing COL1AI expression195

Alcohol-induced liver injury: crosslinking196 Cross-linked by tranglutaminase 2 leading to loss of transcription factor function and induction of apoptosis196

HCC: Upregulated85 Promotes tumor invasion and migration through expression of matrix metalloproteinase 2197 and transactivation of CD151198; involved in aberrant histone acetylation199; Promotes proliferation256; Promotes expression of HULC lnRNA, which induces cell proliferation and survival200

SP2 Gastric cancer: Upregulated43 Gastric cancer: Promotes cell proliferation43

SP3 The Gastric epithelium Stomach: Promotes production of REG1 under stress-induced damage255 Gastric cancer: Expressed but no differential expression pattern noted Gastric cancer: Promotes cell invasion45

Intestinal epithelium Promotes apoptosis 79, 80; Promotes expression of Na+/H+ exchangers NHEs69-71; Promotes expression of EK176 CRC: Expression pattern not noted CRC: Promotes cell proliferation, survival, and invasion85; Promotes apoptosis 91

Pancreas: beta cell155 Regulate expression of PDX1 with SP1155 PDAC: Upregulated85

Pancreas: ductal epithelial cell153 Regulates expression of SCTR, secretin receptor gene with SP1153

HCC: Upregulated85 Promotes expression of HULC lnRNA, which increases cell proliferation and survival200

SP4 CRC: Expression pattern not noted CRC: promotes cell proliferation, survival, and invasion85

PDAC: Upregulated85

HCC: Upregulated85 Promotes expression of HULC lnRNA, which increases cell proliferation and survival200

SP5 Gastric cancer: Upregulated44

CRC: Upregulated44

SP6 Low expression in the crypts of the duodenum257

SP7 Stomach: Parietal cells37

Intestines: Differentiated cells37

SP8 ND (not determined) ND

SP9 ND ND

KLF1 ND ND

KLF2 Pancreas190 PDAC: Downregulated258 Inhibits cell proliferation and migration258

Liver222 Acute Liver Injury: Downregulated223 Vasoprotective, promotes autophagy in liver sinusoid endothelial cells223

Cirrhotic Liver: Downregulated222, 226, 227 Protects against endothelial damage, reduce portal hypertension222; Inhibits the activation of HSCs 226, 227

KLF3 ND ND

KLF4 Oral Mucosa18 OSCC: Downregulated in high grade cancer14, 18, 19 Has tumor suppressor function18, 19 and has higher expression in low grade OSCC14

Esophagus: Suprabasal layer26 Esophagus: Cell differentiation and maturation26 Barrett’s esophagus: Overexpressed in BE specimens; Barrett’s esophagus: Involved in the metaplasia of squamous epithelium to columnar epithelium29, 30;
Esophageal squamous carcinoma: Loss of expression in human ESCC specimens32; increased expression observed in advanced stage ESCC31 ESCC: Context-dependent functions as an oncoprotein or tumor-suppressor depending on the stage. At early stage, functions as a tumor suppressor and induces cell differentiation 32, 259. At later stage, increased expression was observed31

Stomach: Differentiated mid- to upper part of the epithelium46 Stomach: Cell proliferation and cell fate determination47; ghrelin and histamine production46, 48 Gastric cancer: Loss of KLF4 expression49, 50 Gastric cancer: Functions as a tumor suppressor by inhibiting cell proliferation and inducing apoptosis49, 54

Small and large intestines: Differentiated cells of the small intestinal villi or luminal surface of the colonic epithelium100-103 Small and large intestines: Cell cycle regulation100-102; Anti-apoptotic factor97, 98, 103, 104; Cell differentiation96, 99, 107, 112 Colorectal cancer: Loss of KLF4 exprssion127-130 IBD: protects against DSS-induced colitis; CRC: Functions as a tumor suppressor; Associated with LNM and poor survival129, 130; Regulates cell cycle127, 131; Inhibits cell invasion135; Functions as an oncogenic factor by promoting anti-apoptotic effects in cells with mutant KRASV12 260

Pancreas: Ductal Epithelial Cells22, 176 Transactivates KRT19 expression174, 175 PDAC: Required for precursor lesion formation during early tumorigenesis; Downregulated in later stages of tumorigenesis171, 172, 177 Cell cycle arrest via upregulate p27Kip1 expression171; Inhibits LDHA expression171; Suppresses metastasis171, 172; Required for acinar-to-ductal metaplasia and PanIN formation177

Liver232 HCC: Downregulated232, 234-236 Tumor suppressor by inhibiting migration and invasion232, 234-236

KLF5 Oral Mucosa15 OSCC: Upregulated15 Promotes cancer growth and survival15

Esophagus: Basal (proliferative) layer25 Esophagus: Cell proliferation25; cell migration28 ESCC: Downregulated33-35 ESCC: Inhibits tumor invasion33; Anti-proliferative factor34; Pro-apoptotic factor35

Gastric epithelium56, 57 Gastric cancer: Upregulated56, 57 Gastric cancer: Associated with higher tumor grade LMN, and lower survival rate57; Involved in H pylori-infection mediated gastric-to-intestinal trans-differentiation58, 59

The intestinal epithelium: Expressed in proliferating cells of the crypts24 Regulates cell proliferation117, 261; Regulates cell cycle progression139, 146, 262; Promotes cell differentiation and barrier function116; Maintains stem cell markers and functions117, 119, 120; Involved in intestinal epithelial regeneration124, 125; DNA damage repair125 IBD: Intestinal epithelial regeneration121-123 CRC: Increased cell proliferation139-141; Promotes nuclear translocation of β-catenin and transcriptional functions144, 145; Promotes oncogenic transformation of Lgr5-expressing stem cells138; Mediates the oncogenic functions of KRASV12G146, 147

Pancreas183 PDAC: Upregulated179-181, 183, 184 Promotes cancer cell growth179-181 and cell survival184; Promotes epithelial phenotype183

Liver219 Non-alcoholic steatohepatitis: Upregulated219 Promote triglyceride synthesis by activating PPARG expression219

KLF6 Gastric cancer: downregulated61, 62; Variant form of KLF6 (KLF6-SV1) expressed64 Gastric cancer: Functions as a tumor suppressor by transcriptionally regulating CDKN1A, c-MYC62; Associated with poor cell differentiation, LMN and TNM stage63; KLF6-SV1 functions as an oncogenic factor and dominant negative regulator of full-length KLF664

CRC: Downregulated or lost148-150

Liver201 Required for organogenesis of liver191, 201 Non-alcoholic steatohepatitis: Upregulated214, 215, 217 KLF6-IVS1-27G>A single nucleotide polymorphism is associated with increased SV1 spliced variant, increased steatosis215 and decreased fibrosis214; Increase steatosis by expression of PPARA and PPARG217

HCC: Full length variant downregulated; SV1 spliced variant upregulated244 Full length variant act as a tumor suppressor239,240-244; SV1 variant inhibits tumor suppressor function of full length variant244

KLF7 ND ND

KLF8 Gastric cancer: Upregulated65, 66 GC: Associated with poor prognosis, LNM and TNM staging65, 66; Promotes cell proliferation and EMT67, 68

HCC: Upregulated248 Increases tumor invasion248, 249; Promotes cancer cell proliferation and survival248

KLF9 Esophagus263 ESCC: Downregulated263 ESCC: Tumor suppressor; Forced expression inhibits growth, migration, and metastasis263

Small and large intestines: smooth muscle cells126 Regulates proliferation and intestinal morphogenesis126 CRC: Downregulated152 CRC: Prevents tumor formation152

Liver: Hepatocytes206-208 Regulates the expression of P450 enzymes important for detoxification207, 208; Has a role in regulating CYP7A in bile acid synthesis206 Non-alcoholic steatohepatitis: Upregulated217 Activates expression of PPARG, as does KLF6217

HCC: Downregulated251 Tumor suppressor functions through increasing expression of TP53251

KLF10 Pancreas185 Islet Cell: Important for maintaining beta-cell mass and function185 PDAC: Downregulated170, 252 Inhibits cell growth and induces apoptosis in response to TGFB170, 252

HCC: Downregulated252 Mediates the TGFB induced apoptosis252

KLF11 Pancreas: Acinar cells166 Promotes acinar cell differentiation and senescence and suppresses oxidative stress response genes166 PDAC: Downregulated166, 168, 169 Inhibits cell proliferation; induces apoptosis in response to TGFB166, 168, 169

Pancreas: Islet cells187 Maintains normal beta-cell function187 French mature-onset diabetes of the young; mutations in KLF11 gene187 Loss of ability to transactivate PDX1, required for beta-cell function187

Neonatal diabetes mellitus: Mutation in cis-regulatory element in insulin promoter189 Mutation in insulin promoter prevents KLF11 transactivation of the insulin gene189

Liver264 Non-alcoholic steatohepatitis: Upregulated218 Activates expression of PPARA and promotes steatosis218

Cirrhotic Liver: Upregulated231 Directly activates expression of collagen 1a2 and induce fibrosis231

KLF12 ND ND

KLF13 ND ND

KLF14 Liver: Hepatocytes209, 210 Increases signaling lipid production by activating SK1209; Regulates expression of APOAI gene210

KLF15 Liver: Hepatocytes204, 205 Regulates gluconeogenesis by regulating amino acid utilization204 and PEPCK expression205 Non-alcoholic steatohepatitis: Upregulated220 Promotes steatosis by promoting insulin resistance and lipid accumulation220

KLF16 ND ND

KLF17 Esophagus265 ESCC: Downregulated265 ESCC: Decreased expression correlated with metastasis265

Gastric cancer: Downregulated266 Gastric cancer: Associated with tumor size, LMN, and poor survival266

HCC: Downregulated253, 254 Inhibits tumor invasion and migration253, 254